GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (TSX:GTMS) » Definitions » YoY EBITDA Growth

Greenbrook TMS (TSX:GTMS) YoY EBITDA Growth : 37.05% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Greenbrook TMS's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 37.05%.

Greenbrook TMS's EBITDA per Share for the three months ended in Sep. 2023 was C$-0.30.


Greenbrook TMS YoY EBITDA Growth Historical Data

The historical data trend for Greenbrook TMS's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS YoY EBITDA Growth Chart

Greenbrook TMS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial -135.29 -58.95 -77.48 46.97 -196.57

Greenbrook TMS Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -642.19 -317.39 62.54 15.38 37.05

Greenbrook TMS YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Greenbrook TMS's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-3.372--1.137)/ | -1.137 |
=-196.57 %

Greenbrook TMS's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.299--0.475)/ | -0.475 |
=37.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenbrook TMS YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenbrook TMS (TSX:GTMS) Business Description

Traded in Other Exchanges
Address
890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (TSX:GTMS) Headlines

No Headlines